LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 28

Search options

  1. Book: Detection of SARS-CoV-2 antibodies in diagnosis and treatment of COVID-19

    Simmons, Daimon P.

    (Clinics in laboratory medicine ; volume 42, number 1 (March 2022))

    2022  

    Author's details editors Daimon P. Simmons, Peter H. Schur
    Series title Clinics in laboratory medicine ; volume 42, number 1 (March 2022)
    Collection
    Language English
    Size xiii, 128 Seiten, Illustrationen
    Publisher Elsevier
    Publishing place Philadelphia, Pennsylvania
    Publishing country United States
    Document type Book
    HBZ-ID HT021367380
    ISBN 978-0-323-83586-2 ; 0-323-83586-4
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Article ; Online: Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management.

    Simmons, Daimon P / Schur, Peter H

    Clinics in laboratory medicine

    2021  Volume 42, Issue 1, Page(s) xi–xiii

    Language English
    Publishing date 2021-12-21
    Publishing country United States
    Document type Editorial
    ZDB-ID 604580-7
    ISSN 1557-9832 ; 0272-2712
    ISSN (online) 1557-9832
    ISSN 0272-2712
    DOI 10.1016/j.cll.2021.12.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utility.

    Tolan, Nicole V / DeSimone, Mia S / Fernandes, Maria D / Lewis, Joshua E / Simmons, Daimon P / Schur, Peter H / Brigl, Manfred / Tanasijevic, Milenko J / Desjardins, Michaël / Sherman, Amy C / Baden, Lindsey R / Snyder, Marion / Melanson, Stacy Ef

    Clinical biochemistry

    2023  Volume 117, Page(s) 60–68

    Abstract: ... TOT was observed for Moderna vaccine recipients then Pfizer (p-values < 0.0001). A sustained RS TOT ... lower RS TOT than healthy VD (p < 0.0001) at dose 2 and 4 weeks after.: Conclusions: Our data ...

    Abstract Background: Serologic assays for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been proposed to assist with the acute diagnosis of infection, support epidemiological studies, identify convalescent plasma donors, and evaluate vaccine response.
    Methods: We report an evaluation of nine serologic assays: Abbott (AB) and Epitope (EP) IgG and IgM, EUROIMMUN (EU) IgG and IgA, Roche anti-N (RN TOT) and anti-S (RS TOT) total antibody, and DiaSorin (DS) IgG. We evaluated 291 negative controls (NEG CTRL), 91 PCR positive (PCR POS) patients (179 samples), 126 convalescent plasma donors (CPD), 27 healthy vaccinated donors (VD), and 20 allogeneic hematopoietic stem cell transplant (HSCT) recipients (45 samples).
    Results: We observed good agreement with the method performance claims for specificity (93-100%) in NEG CTRL but only 85% for EU IgA. The sensitivity claims in the first 2 weeks of symptom onset was lower (26-61%) than performance claims based on > 2 weeks since PCR positivity. We observed high sensitivities (94-100%) in CPD except for AB IgM (77%), EP IgM (0%). Significantly higher RS TOT was observed for Moderna vaccine recipients then Pfizer (p-values < 0.0001). A sustained RS TOT response was observed for the five months following vaccination. HSCT recipients demonstrated significantly lower RS TOT than healthy VD (p < 0.0001) at dose 2 and 4 weeks after.
    Conclusions: Our data suggests against the use of anti-SARS-CoV-2 assays to aid in acute diagnosis. RN TOT and RS TOT can readily identify past-resolved infection and vaccine response in the absence of native infection. We provide an estimate of expected antibody response in healthy VD over the time course of vaccination for which to compare antibody responses in immunosuppressed patients.
    MeSH term(s) Humans ; COVID-19/diagnosis ; SARS-CoV-2 ; Sensitivity and Specificity ; Antibodies, Viral ; Immunoglobulin G ; COVID-19 Serotherapy ; Immunoglobulin M ; Immunoglobulin A ; COVID-19 Testing
    Chemical Substances Antibodies, Viral ; Immunoglobulin G ; Immunoglobulin M ; Immunoglobulin A
    Language English
    Publishing date 2023-03-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 390372-2
    ISSN 1873-2933 ; 0009-9120
    ISSN (online) 1873-2933
    ISSN 0009-9120
    DOI 10.1016/j.clinbiochem.2023.03.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Hemolysis from ABO Incompatibility.

    Simmons, Daimon P / Savage, William J

    Hematology/oncology clinics of North America

    2015  Volume 29, Issue 3, Page(s) 429–443

    Abstract: ABO incompatibility of red blood cells leads to brisk complement-mediated lysis, particularly in the setting of red cell transfusion. The ABO blood group is the most clinically significant blood group because of preformed immunoglobulin M (IgM) and IgG ... ...

    Abstract ABO incompatibility of red blood cells leads to brisk complement-mediated lysis, particularly in the setting of red cell transfusion. The ABO blood group is the most clinically significant blood group because of preformed immunoglobulin M (IgM) and IgG antibodies to ABO blood group antigens (isohemagglutinins) in everyone except group AB individuals. In addition to transfusion, ABO incompatibility can cause hemolysis in hematopoietic and solid organ transplantation, hemolytic disease of the newborn, and intravenous immunoglobulin infusion. It is important to prevent ABO incompatibility when possible and to anticipate complications when ABO incompatibility is unavoidable.
    MeSH term(s) ABO Blood-Group System/immunology ; Blood Group Incompatibility/etiology ; Blood Group Incompatibility/immunology ; Blood Group Incompatibility/prevention & control ; Blood Grouping and Crossmatching/methods ; Cell Transplantation/adverse effects ; Hemolysis/immunology ; Humans ; Models, Immunological ; Tissue Transplantation/adverse effects ; Transfusion Reaction
    Chemical Substances ABO Blood-Group System
    Language English
    Publishing date 2015-06
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 93115-9
    ISSN 1558-1977 ; 0889-8588
    ISSN (online) 1558-1977
    ISSN 0889-8588
    DOI 10.1016/j.hoc.2015.01.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Adipocytes regulate fibroblast function, and their loss contributes to fibroblast dysfunction in inflammatory diseases.

    Faust, Heather J / Cheng, Tan-Yun / Korsunsky, Ilya / Watts, Gerald F M / Gal-Oz, Shani T / Trim, William / Kongthong, Kurt / Jonsson, Anna Helena / Simmons, Daimon P / Zhang, Fan / Padera, Robert / Chubinskaya, Susan / Wei, Kevin / Raychaudhuri, Soumya / Lynch, Lydia / Moody, D Branch / Brenner, Michael B

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Fibroblasts play critical roles in tissue homeostasis, but in pathologic states can drive fibrosis, inflammation, and tissue destruction. In the joint synovium, fibroblasts provide homeostatic maintenance and lubrication. Little is known about what ... ...

    Abstract Fibroblasts play critical roles in tissue homeostasis, but in pathologic states can drive fibrosis, inflammation, and tissue destruction. In the joint synovium, fibroblasts provide homeostatic maintenance and lubrication. Little is known about what regulates the homeostatic functions of fibroblasts in healthy conditions. We performed RNA sequencing of healthy human synovial tissue and identified a fibroblast gene expression program characterized by enhanced fatty acid metabolism and lipid transport. We found that fat-conditioned media reproduces key aspects of the lipid-related gene signature in cultured fibroblasts. Fractionation and mass spectrometry identified cortisol in driving the healthy fibroblast phenotype, confirmed using glucocorticoid receptor gene (
    Language English
    Publishing date 2023-05-18
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.05.16.540975
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Impact of allele-specific anti-human leukocyte antigen class I antibodies on organ allocation.

    Yeung, Melissa Y / Murakami, Naoka / Kafetzi, Maria L / Simmons, Daimon P / Wood, Isabelle / Macaskill, Peter / Towle, Matthew / DellaGatta, Jamie / Stevens, Jonathan / Comeau, Edward / Baronas, Jane / Mohsin, Nabil / Chen, Mike / Lee, Jar-How / Lane, William J / Milford, Edgar L / Guleria, Indira

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

    2023  Volume 23, Issue 9, Page(s) 1388–1400

    Abstract: Technological advances in the field of histocompatibility have allowed us to define anti-human leukocyte antigen (HLA) antibody specificity at the allelic level. However, how allele-specific antibodies affect organ allocation is poorly studied. We ... ...

    Abstract Technological advances in the field of histocompatibility have allowed us to define anti-human leukocyte antigen (HLA) antibody specificity at the allelic level. However, how allele-specific antibodies affect organ allocation is poorly studied. We examined allelic specificities of class I HLA antibodies in 6726 consecutive serum samples from 2953 transplant candidates and evaluated their impact on the corresponding crossmatch and organ allocation. Out of 17 class I HLA antigens represented by >1 allele in the LABScreen single antigen bead assay, 12 had potential allele-specific reactivity. Taking advantage of our unbiased cohort of deceased donor-candidate testing (123,135 complement-dependent cytotoxicity crossmatches between 2014 and 2017), we estimated that the presence of allele-specific antibody detected using a single antigen bead assay (median fluorescence intensity, >3000) against only the rare allele was a poor predictor of a positive complement-dependent cytotoxicity crossmatch, with a positive predictive value of 0% to 7%, compared with 52.5% in allele-concordant class I HLA antibodies against A or B locus antigens. Further, we confirmed allele-specific reactivity using flow crossmatch in 3 scenarios: A11:01/A11:02, A68:01/A68:02, and B44:02/B44:03. Our results suggest that allele-specific antibodies may unnecessarily exclude transplant candidates (up to 10%) from organ offers by overcalling unacceptable antigens; incorporation of selective reactivity pattern in allocation may promote precision matching and more equitable allocation.
    MeSH term(s) Humans ; Isoantibodies ; Alleles ; Histocompatibility Testing/methods ; Histocompatibility Antigens Class I/genetics ; HLA Antigens/genetics ; Antigens
    Chemical Substances Isoantibodies ; Histocompatibility Antigens Class I ; HLA Antigens ; Antigens
    Language English
    Publishing date 2023-05-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2060594-8
    ISSN 1600-6143 ; 1600-6135
    ISSN (online) 1600-6143
    ISSN 1600-6135
    DOI 10.1016/j.ajt.2023.05.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: High-dimensional immunophenotyping reveals immune cell aberrations in patients with undiagnosed inflammatory and autoimmune diseases.

    Mueller, Alisa A / Sasaki, Takanori / Keegan, Joshua W / Nguyen, Jennifer P / Griffith, Alec / Horisberger, Alice M / Licata, Thomas / Fieg, Elizabeth / Cao, Ye / Elahee, Mehreen / Marks, Kathryne E / Simmons, Daimon P / Briere, Lauren C / Cobban, Laurel A / Pallais, J Carl / High, Frances A / Walker, Melissa A / Linnoila, Jenny J / Sparks, Jeffrey A /
    Holers, V Michael / Costenbader, Karen H / Sweetser, David A / Krier, Joel B / Loscalzo, Joseph / Lederer, James A / Rao, Deepak A

    The Journal of clinical investigation

    2023  Volume 133, Issue 24

    MeSH term(s) Humans ; Immunophenotyping ; Autoimmune Diseases/diagnosis ; Autoimmunity
    Language English
    Publishing date 2023-12-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI169619
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A Two-Cell Model for IL-1β Release Mediated by Death-Receptor Signaling.

    Donado, Carlos A / Cao, Anh B / Simmons, Daimon P / Croker, Ben A / Brennan, Patrick J / Brenner, Michael B

    Cell reports

    2020  Volume 31, Issue 1, Page(s) 107466

    Abstract: Interleukin-1β (IL-1β) is a key orchestrator of anti-microbial immunity whose secretion is typically dependent on activation of inflammasomes. However, many pathogens have evolved strategies to evade inflammasome activation. Here we describe an ... ...

    Abstract Interleukin-1β (IL-1β) is a key orchestrator of anti-microbial immunity whose secretion is typically dependent on activation of inflammasomes. However, many pathogens have evolved strategies to evade inflammasome activation. Here we describe an alternative, two-cell model for IL-1β release where invariant natural killer T (iNKT) cells use the death receptor pathway to instruct antigen-presenting cells to secrete IL-1β. Following cognate interactions with TLR-primed bone marrow-derived dendritic cells (BMDCs), iNKT cells rapidly translocate intracellular Fas ligand to the surface to engage Fas on BMDCs. Fas ligation activates a caspase-8-dependent signaling cascade in BMDCs that drives IL-1β release largely independent of inflammasomes. The apoptotic program initiated by Fas ligation rapidly transitions into a pyroptosis-like form of cell death mediated by gasdermin D. Together, our findings support a two-cell model for IL-1β secretion that may supersede inflammasome activation when cytosolic triggers fail.
    MeSH term(s) Animals ; Apoptosis ; Caspase 1/metabolism ; Caspase 8/metabolism ; Dendritic Cells/metabolism ; Female ; Humans ; Inflammasomes/metabolism ; Interleukin-1beta/metabolism ; Interleukin-1beta/physiology ; Male ; Mice ; Mice, Inbred C57BL ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Natural Killer T-Cells/metabolism ; Pyroptosis ; Receptors, Death Domain/metabolism ; Signal Transduction
    Chemical Substances IL1B protein, human ; Inflammasomes ; Interleukin-1beta ; NLR Family, Pyrin Domain-Containing 3 Protein ; Receptors, Death Domain ; CASP8 protein, human (EC 3.4.22.-) ; Caspase 8 (EC 3.4.22.-) ; Caspase 1 (EC 3.4.22.36)
    Language English
    Publishing date 2020-03-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2020.03.030
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: A Two-Cell Model for IL-1β Release Mediated by Death-Receptor Signaling

    Carlos A. Donado / Anh B. Cao / Daimon P. Simmons / Ben A. Croker / Patrick J. Brennan / Michael B. Brenner

    Cell Reports, Vol 31, Iss 1, Pp - (2020)

    2020  

    Abstract: Summary: Interleukin-1β (IL-1β) is a key orchestrator of anti-microbial immunity whose secretion is typically dependent on activation of inflammasomes. However, many pathogens have evolved strategies to evade inflammasome activation. Here we describe an ... ...

    Abstract Summary: Interleukin-1β (IL-1β) is a key orchestrator of anti-microbial immunity whose secretion is typically dependent on activation of inflammasomes. However, many pathogens have evolved strategies to evade inflammasome activation. Here we describe an alternative, two-cell model for IL-1β release where invariant natural killer T (iNKT) cells use the death receptor pathway to instruct antigen-presenting cells to secrete IL-1β. Following cognate interactions with TLR-primed bone marrow-derived dendritic cells (BMDCs), iNKT cells rapidly translocate intracellular Fas ligand to the surface to engage Fas on BMDCs. Fas ligation activates a caspase-8-dependent signaling cascade in BMDCs that drives IL-1β release largely independent of inflammasomes. The apoptotic program initiated by Fas ligation rapidly transitions into a pyroptosis-like form of cell death mediated by gasdermin D. Together, our findings support a two-cell model for IL-1β secretion that may supersede inflammasome activation when cytosolic triggers fail. : How the immune system triggers IL-1β release during infection with inflammasome-evasive microbes is largely unknown. Donado et al. describe an alternative, caspase-8-dependent IL-1β secretion pathway where a second cell, the invariant natural killer T (iNKT) cell, can provide antigen-presenting cells with cell-extrinsic IL-1β release signals through FasL. Keywords: interleukin-1, inflammasome, cell death, Fas, Fas ligand, NKT cell, caspase, gasdermin, apoptosis, pyroptosis
    Keywords Biology (General) ; QH301-705.5
    Subject code 570
    Language English
    Publishing date 2020-04-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Validation and Implementation of an Ordering Alert to Improve the Efficiency of Monoclonal Gammopathy Evaluation.

    Uljon, Sacha N / Simmons, Daimon P / Rudolf, Joseph W / Baron, Jason M / Dutta, Sayon / McEvoy, Dustin S / Murali, Mandakolathur / Dighe, Anand S

    American journal of clinical pathology

    2019  Volume 153, Issue 3, Page(s) 396–406

    Abstract: Objectives: To evaluate the use of a provider ordering alert to improve laboratory efficiency and reduce costs.: Methods: We conducted a retrospective study to assess the use of an institutional reflex panel for monoclonal gammopathy evaluation. We ... ...

    Abstract Objectives: To evaluate the use of a provider ordering alert to improve laboratory efficiency and reduce costs.
    Methods: We conducted a retrospective study to assess the use of an institutional reflex panel for monoclonal gammopathy evaluation. We then created a clinical decision support (CDS) alert to educate and encourage providers to change their less-efficient orders to the reflex panel.
    Results: Our retrospective analysis demonstrated that an institutional reflex panel could be safely substituted for a less-efficient and higher-cost panel. The implemented CDS alert resulted in 79% of providers changing their high-cost order panel to an order panel based on the reflex algorithm.
    Conclusions: The validated decision support alert demonstrated high levels of provider acceptance and directly led to operational and cost savings within the laboratory. Furthermore, these studies highlight the value of laboratory involvement with CDS efforts to provide agile and targeted provider ordering assistance.
    MeSH term(s) Cost Savings ; Decision Support Systems, Clinical/economics ; Efficiency ; Humans ; Medical Order Entry Systems ; Paraproteinemias/diagnosis ; Practice Patterns, Physicians'/economics ; Retrospective Studies
    Language English
    Publishing date 2019-11-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 2944-0
    ISSN 1943-7722 ; 0002-9173
    ISSN (online) 1943-7722
    ISSN 0002-9173
    DOI 10.1093/ajcp/aqz180
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top